Literature DB >> 15988728

Characterization of moenomycin antibiotics from medicated chicken feed by ion-trap mass spectrometry with electrospray ionization.

Peter Eichhorn1, Diana S Aga.   

Abstract

The antimicrobial moenomycin, commonly used as a growth promoter in livestock, was isolated from medicated chicken feed. The purified extract was subjected to reversed-phase liquid chromatographic separation followed by structural characterization using ion-trap mass spectrometry (ITMS), which allowed identification of five moenomycins (A, A12, C1, C3, and C4) as the major components. The fragmentation patterns of the protonated and deprotonated moenomycin molecules, as well as of a series of sodium adducts, were investigated using ITMS after electrospray ionization. While the protonated molecules [M+H]+ proved highly unstable and underwent extensive in-source fragmentation, isolation and activation of the [M--H]- ions (m/z 1580 for moenomycin-A) yielded simple mass spectra with a dominant base peak corresponding to the loss of the carboxy-glycol and the C25-hydrocarbon chain (m/z 1152 for moenomycin-A). Further study of this fragment ion in an MS3 experiment gave rise to a peculiar product ion (m/z 902 for moenomycin-A) that was attributed to the expulsion of a carbohydrate moiety representing a central building block of the linear molecule. In positive ion mode the generation of the mono-sodiated adduct ions, [M+Na]+, was promoted by amending the mobile phase with 100 microM sodium acetate, but this also resulted in higher adducts of the type [M+2Na--H]+ and [M+3Na--2H]+ arising from the formation of the sodium salts of the phosphate acid diester and subsequently of the carboxylic acid. Substantial differences among the fragment-rich product ion profiles of the three species were observed, and could in part be traced back to the mode of complexation of the additional sodium cation(s). (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15988728     DOI: 10.1002/rcm.2044

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  6 in total

1.  Characterization of moenomycin antibiotic complex by multistage MALDI-IT/RTOF-MS and ESI-IT-MS.

Authors:  Martin Zehl; Ernst Pittenauer; Andreas Rizzi; Guenter Allmaier
Journal:  J Am Soc Mass Spectrom       Date:  2006-05-30       Impact factor: 3.109

2.  A streamlined metabolic pathway for the biosynthesis of moenomycin A.

Authors:  Bohdan Ostash; Alan Saghatelian; Suzanne Walker
Journal:  Chem Biol       Date:  2007-03

3.  Complete characterization of the seventeen step moenomycin biosynthetic pathway.

Authors:  Bohdan Ostash; Emma H Doud; Cecilie Lin; Iryna Ostash; Deborah L Perlstein; Shinichiro Fuse; Manuel Wolpert; Daniel Kahne; Suzanne Walker
Journal:  Biochemistry       Date:  2009-09-22       Impact factor: 3.162

4.  MoeH5: a natural glycorandomizer from the moenomycin biosynthetic pathway.

Authors:  Bohdan Ostash; Jennifer Campbell; Andriy Luzhetskyy; Suzanne Walker
Journal:  Mol Microbiol       Date:  2013-11-21       Impact factor: 3.501

Review 5.  Bioactive oligosaccharide natural products.

Authors:  Emilianne K McCranie; Brian O Bachmann
Journal:  Nat Prod Rep       Date:  2014-08       Impact factor: 13.423

6.  Domain requirement of moenomycin binding to bifunctional transglycosylases and development of high-throughput discovery of antibiotics.

Authors:  Ting-Jen Rachel Cheng; Ming-Ta Sung; Hsin-Yu Liao; Yi-Fan Chang; Chia-Wei Chen; Chia-Ying Huang; Lien-Yang Chou; Yen-Da Wu; Yin-Hsuan Chen; Yih-Shyun E Cheng; Chi-Huey Wong; Che Ma; Wei-Chieh Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-08       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.